Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Big Rock Partners Acquisition Corp (NQ: BRPA )

30.82 USD -5.08 (-14.15%)
Official Closing Price Updated: 6:37 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,600
Open 33.86
Bid (Size) 30.90 (1)
Ask (Size) 32.89 (4)
Prev. Close 35.90
Today's Range 28.62 - 33.86
52wk Range 10.50 - 76.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
NeuroRx Responds to Issues Raised by Relief Therapeutics Regarding ZYESAMI development
The issues raised by Relief Therapeutics in its release dated April 19, 2021 have no bearing on NeuroRx's ability or commitment to deliver a safe, effective, and stable lifesaving drug on a worldwide... 
From PR Newswire
Big Rock Partners Acquisition Corp. Clarifies Procedure for Stockholder Conversions and Urges Stockholders To Vote "For" Extension Amendment Proposal
From ACCESSWIRE

Performance

YTD
+28.36%
+28.36%
1 Month
+14.15%
+14.15%
3 Month
-5.46%
-5.46%
6 Month
+185.80%
+185.80%
1 Year
+188.58%
+188.58%

More News

Read More
NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir
From PR Newswire
/C O R R E C T I O N -- NeuroRx/
From PR Newswire
NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19
From PR Newswire
NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure
From PR Newswire
Neurorx, Inc. and Big Rock Partners Acquisition Corp. Announce Committed $10 Million Pipe to Support Proposed Business Combination
From ACCESSWIRE
SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, BRPA, and KTYB Shareholders About Its Ongoing Investigations
From PR Newswire
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.